YUVEZZI

Visus Therapeutics, Inc.🇺🇸 United States

FDA Page

Effective Date: May 27, 2026
Approval ID: 68198098-0f33-458f-83b8-eb2a5ec69012
Products: 1 registered
Version: 4

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use YUVEZZI™ safely and effectively. See full prescribing information for YUVEZZI. YUVEZZI (carbachol and brimonidine tartrate ophthalmic solution) 2.75% / 0.1%, for topical ophthalmic use Initial U.S. Approval: 2026

Quick Stats

Total Products1

Labelers1

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.